About: Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $30.43 (-1.85%)
CLDX NASDAQ Celldex Therapeutics Inc
Celldex Therapeutics Inc share price
CLDX price activity
Último preço
$ 30,430
Variação (24h)
-0,58 USD (-1,85%)
Volume
1.75M
Volume (média 4 sem.)
-
Abertura
$ 30,62
Variação do dia
$ 30,11 - $ 31,35
Fechamento anterior
$ 31,01
Último negócio
07 Oct, 8:02 pm GMT+0
Atrasado
07 Oct, 8:02 pm GMT+0
CLDX price performance
Atrasado
07 Oct, 8:02 pm GMT+0
quote.marketSignals